The Effective Duration of Antimicrobial Activity of Mafenide Acetate After Reconstitution

Area of Science:

• Microbiology
• Pharmacology
• Wound Care

Background:

• Mafenide acetate is a crucial antimicrobial for burn wound management.
• Current guidelines mandate discarding unused solution within 48 hours of opening.
• This leads to significant product waste and increased treatment costs.

Purpose of the Study:

• To evaluate the in vitro antimicrobial efficacy of mafenide acetate beyond the recommended 48-hour discard period.
• To determine if extending the usability of reconstituted mafenide acetate can reduce product waste and associated costs.

Main Methods:

• Standardized antimicrobial susceptibility testing was performed.
• Mueller-Hinton agar plates were inoculated with Staphylococcus aureus and Pseudomonas aeruginosa.
• Filter paper disks saturated with 5% mafenide acetate were applied at various time points (0, 2, 7, 14, 30, 60 days) post-reconstitution.
• Zones of inhibition were measured after incubation.

Main Results:

• Mafenide acetate demonstrated consistent antimicrobial activity against both S. aureus and P. aeruginosa.
• Zones of inhibition greater than 2 mm were observed at all tested time points up to 60 days post-reconstitution.
• The antimicrobial efficacy remained stable throughout the 60-day study period.

Conclusions:

• Mafenide acetate retains significant antimicrobial activity for at least 60 days after reconstitution.
• The 48-hour discard recommendation may be overly conservative, suggesting potential for cost savings.
• Further clinical studies are warranted to confirm these in vitro findings in a clinical setting.